Hercules Capital is a private equity general partner firm headquartered in Palo Alto, CA, United States and has other offices in United States.
Hercules Capital has invested $30m in Concert Pharmaceuticals, a MA-based clinical-stage biopharmaceutical company.
Hercules Capital has invested $55m in biopharmaceutical company focused on treating dementia Axovant Sciences.
Aprecia, a commercial stage pharmaceutical company, has entered into an up to $30m debt financing agreement with Hercules Capital.
Read more news concerning Hercules Capital
A sampling of Hercules Capital portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?